Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

cbdMD (YCBD) Equity Average (2017 - 2025)

cbdMD's Equity Average history spans 9 years, with the latest figure at $8.1 million for Q4 2025.

  • For Q4 2025, Equity Average rose 333.49% year-over-year to $8.1 million; the TTM value through Dec 2025 reached $8.1 million, up 333.49%, while the annual FY2025 figure was $4.6 million, 16.42% down from the prior year.
  • Equity Average for Q4 2025 was $8.1 million at cbdMD, up from $6.7 million in the prior quarter.
  • Across five years, Equity Average topped out at $96.2 million in Q3 2021 and bottomed at $1.2 million in Q1 2025.
  • The 5-year median for Equity Average is $21.6 million (2023), against an average of $34.3 million.
  • The largest annual shift saw Equity Average crashed 88.13% in 2024 before it soared 333.49% in 2025.
  • A 5-year view of Equity Average shows it stood at $93.8 million in 2021, then tumbled by 69.07% to $29.0 million in 2022, then plummeted by 72.3% to $8.0 million in 2023, then crashed by 76.69% to $1.9 million in 2024, then soared by 333.49% to $8.1 million in 2025.
  • Per Business Quant, the three most recent readings for YCBD's Equity Average are $8.1 million (Q4 2025), $6.7 million (Q3 2025), and $3.4 million (Q2 2025).